• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义流感 A 病毒液滴凝聚体的基本规则。

Defining basic rules for hardening influenza A virus liquid condensates.

机构信息

Cell Biology of Viral Infection Lab, Instituto Gulbenkian de Ciência, Oeiras, Portugal.

European Molecular Biology Laboratory, Heidelberg, Germany.

出版信息

Elife. 2023 Apr 4;12:e85182. doi: 10.7554/eLife.85182.

DOI:10.7554/eLife.85182
PMID:37013374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10154025/
Abstract

In biological systems, liquid and solid-like biomolecular condensates may contain the same molecules but their behaviour, including movement, elasticity, and viscosity, is different on account of distinct physicochemical properties. As such, it is known that phase transitions affect the function of biological condensates and that material properties can be tuned by several factors including temperature, concentration, and valency. It is, however, unclear if some factors are more efficient than others at regulating their behaviour. Viral infections are good systems to address this question as they form condensates as part of their replication programmes. Here, we used influenza A virus (IAV) liquid cytosolic condensates, AKA viral inclusions, to provide a proof of concept that liquid condensate hardening via changes in the valency of its components is more efficient than altering their concentration or the temperature of the cell. Liquid IAV inclusions may be hardened by targeting vRNP (viral ribonucleoprotein) interactions via the known NP (nucleoprotein) oligomerising molecule, nucleozin, both and without affecting host proteome abundance nor solubility. This study is a starting point for understanding how to pharmacologically modulate the material properties of IAV inclusions and may offer opportunities for alternative antiviral strategies.

摘要

在生物系统中,液态和固态类似的生物分子凝聚物可能包含相同的分子,但由于其独特的物理化学性质,它们的行为,包括运动、弹性和粘度,是不同的。因此,人们知道相转变会影响生物凝聚物的功能,并且材料特性可以通过多种因素(包括温度、浓度和价态)进行调节。然而,目前尚不清楚某些因素在调节其行为方面是否比其他因素更有效。病毒感染是一个很好的系统来解决这个问题,因为它们形成凝聚物作为其复制程序的一部分。在这里,我们使用甲型流感病毒 (IAV) 液态胞质凝聚物,又称病毒包涵体,提供了一个概念验证,即通过改变其成分的价态来使液态凝聚物变硬比改变其浓度或细胞温度更有效。通过靶向已知的 NP(核蛋白)寡聚分子核黄素,以及都可以在不影响宿主蛋白质组丰度和溶解度的情况下,使 vRNP(病毒核糖核蛋白)相互作用变硬,液态 IAV 包涵体可以变硬。这项研究是理解如何通过药理学调节 IAV 包涵体的物质特性的起点,并且可能为替代抗病毒策略提供机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/f707a1d37435/elife-85182-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/18b21c2b10be/elife-85182-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/a101979cbe86/elife-85182-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/26f208afd657/elife-85182-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/096f414ec6f1/elife-85182-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/d0fb263fed45/elife-85182-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/6fb6ee888ce8/elife-85182-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/c42ff2af8ed6/elife-85182-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/b50bf6d92114/elife-85182-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/4cc84568bf50/elife-85182-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/aafc5e53a56a/elife-85182-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/56009174505c/elife-85182-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/070e74e491e3/elife-85182-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/6003777fb080/elife-85182-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/7f1f17295625/elife-85182-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/09289390e412/elife-85182-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/f707a1d37435/elife-85182-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/18b21c2b10be/elife-85182-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/a101979cbe86/elife-85182-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/26f208afd657/elife-85182-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/096f414ec6f1/elife-85182-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/d0fb263fed45/elife-85182-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/6fb6ee888ce8/elife-85182-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/c42ff2af8ed6/elife-85182-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/b50bf6d92114/elife-85182-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/4cc84568bf50/elife-85182-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/aafc5e53a56a/elife-85182-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/56009174505c/elife-85182-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/070e74e491e3/elife-85182-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/6003777fb080/elife-85182-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/7f1f17295625/elife-85182-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/09289390e412/elife-85182-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6e/10154025/f707a1d37435/elife-85182-sa2-fig1.jpg

相似文献

1
Defining basic rules for hardening influenza A virus liquid condensates.定义流感 A 病毒液滴凝聚体的基本规则。
Elife. 2023 Apr 4;12:e85182. doi: 10.7554/eLife.85182.
2
Making it hard to replicate.难以复制。
Elife. 2023 Apr 28;12:e88044. doi: 10.7554/eLife.88044.
3
Challenges in Imaging Analyses of Biomolecular Condensates in Cells Infected with Influenza A Virus.细胞感染甲型流感病毒时生物分子凝聚物成像分析的挑战。
Int J Mol Sci. 2023 Oct 17;24(20):15253. doi: 10.3390/ijms242015253.
4
Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives.液体生物分子凝聚物与病毒生命周期:综述与展望。
Viruses. 2021 Feb 25;13(3):366. doi: 10.3390/v13030366.
5
ATG9A regulates the dissociation of recycling endosomes from microtubules to form liquid influenza A virus inclusions.ATG9A 调控回收内体从微管解离以形成液态甲型流感病毒包涵体。
PLoS Biol. 2023 Nov 20;21(11):e3002290. doi: 10.1371/journal.pbio.3002290. eCollection 2023 Nov.
6
The Nucleolar Protein LYAR Facilitates Ribonucleoprotein Assembly of Influenza A Virus.核仁蛋白 LYAR 促进甲型流感病毒核糖核蛋白的组装。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01042-18. Print 2018 Dec 1.
7
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
8
Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus.真核翻译延伸因子 1 德尔塔抑制甲型流感病毒核衣壳蛋白和 PA-PB1 异二聚体的核输入。
J Virol. 2020 Dec 22;95(2). doi: 10.1128/JVI.01391-20.
9
A condensate-hardening drug blocks RSV replication in vivo.一种冷凝硬化药物可阻止 RSV 在体内复制。
Nature. 2021 Jul;595(7868):596-599. doi: 10.1038/s41586-021-03703-z. Epub 2021 Jul 7.
10
Biomolecular Condensates as Novel Antiviral Targets.生物分子凝聚物作为新型抗病毒靶点。
J Mol Biol. 2024 Feb 15;436(4):168380. doi: 10.1016/j.jmb.2023.168380. Epub 2023 Dec 5.

引用本文的文献

1
Nonviral protein cages as tools to decipher and combat viral threats.非病毒蛋白笼作为破译和对抗病毒威胁的工具。
Npj Viruses. 2025 May 26;3(1):45. doi: 10.1038/s44298-025-00127-8.
2
Fast and flu-rious: How to prevent and treat emerging influenza A viruses.快速且肆虐:如何预防和治疗新出现的甲型流感病毒
PLoS Pathog. 2025 May 16;21(5):e1013135. doi: 10.1371/journal.ppat.1013135. eCollection 2025 May.
3
O-GlcNAcylation reduces proteome solubility and regulates the formation of biomolecular condensates in human cells.O-连接的N-乙酰葡糖胺化降低蛋白质组溶解度并调节人类细胞中生物分子凝聚物的形成。

本文引用的文献

1
Molecular mechanisms of stress-induced reactivation in mumps virus condensates.应激诱导的流行性腮腺炎病毒凝聚物再激活的分子机制。
Cell. 2023 Apr 27;186(9):1877-1894.e27. doi: 10.1016/j.cell.2023.03.015.
2
Size distributions of intracellular condensates reflect competition between coalescence and nucleation.细胞内凝聚物的大小分布反映了聚结与成核之间的竞争。
Nat Phys. 2023;19(4):586-596. doi: 10.1038/s41567-022-01917-0. Epub 2023 Feb 2.
3
Systematic discovery of biomolecular condensate-specific protein phosphorylation.系统发现生物分子凝聚物特异性蛋白磷酸化。
Nat Commun. 2025 Apr 30;16(1):4068. doi: 10.1038/s41467-025-59371-4.
4
Unraveling Liquid-Liquid Phase Separation (LLPS) in Viral Infections to Understand and Treat Viral Diseases.解析病毒感染中的液-液相分离(LLPS)以理解和治疗病毒疾病。
Int J Mol Sci. 2024 Jun 26;25(13):6981. doi: 10.3390/ijms25136981.
5
Fluorescent protein tags affect the condensation properties of a phase-separating viral protein.荧光蛋白标签会影响一种发生相分离的病毒蛋白的凝聚特性。
Mol Biol Cell. 2024 Jul 1;35(7):ar100. doi: 10.1091/mbc.E24-01-0013. Epub 2024 May 29.
6
Comparative analysis of human, rodent and snake deltavirus replication.人类、啮齿动物和蛇德尔塔病毒复制的比较分析。
PLoS Pathog. 2024 Mar 5;20(3):e1012060. doi: 10.1371/journal.ppat.1012060. eCollection 2024 Mar.
7
Influenza A virus propagation requires the activation of the unfolded protein response and the accumulation of insoluble protein aggregates.甲型流感病毒的增殖需要激活未折叠蛋白反应并积累不溶性蛋白质聚集体。
iScience. 2024 Feb 2;27(3):109100. doi: 10.1016/j.isci.2024.109100. eCollection 2024 Mar 15.
8
Phosphorylation regulates viral biomolecular condensates to promote infectious progeny production.磷酸化调节病毒生物分子凝聚物以促进感染性后代的产生。
EMBO J. 2024 Jan;43(2):277-303. doi: 10.1038/s44318-023-00021-0. Epub 2024 Jan 2.
9
ATG9A regulates the dissociation of recycling endosomes from microtubules to form liquid influenza A virus inclusions.ATG9A 调控回收内体从微管解离以形成液态甲型流感病毒包涵体。
PLoS Biol. 2023 Nov 20;21(11):e3002290. doi: 10.1371/journal.pbio.3002290. eCollection 2023 Nov.
10
Challenges in Imaging Analyses of Biomolecular Condensates in Cells Infected with Influenza A Virus.细胞感染甲型流感病毒时生物分子凝聚物成像分析的挑战。
Int J Mol Sci. 2023 Oct 17;24(20):15253. doi: 10.3390/ijms242015253.
Nat Chem Biol. 2022 Oct;18(10):1104-1114. doi: 10.1038/s41589-022-01062-y. Epub 2022 Jul 21.
4
Respiratory syncytial virus ribonucleoproteins hijack microtubule Rab11 dependent transport for intracellular trafficking.呼吸道合胞病毒核糖核蛋白劫持微管 Rab11 依赖的运输用于细胞内运输。
PLoS Pathog. 2022 Jul 7;18(7):e1010619. doi: 10.1371/journal.ppat.1010619. eCollection 2022 Jul.
5
TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines.TrackMate 7:将最先进的分割算法集成到跟踪管道中。
Nat Methods. 2022 Jul;19(7):829-832. doi: 10.1038/s41592-022-01507-1. Epub 2022 Jun 2.
6
Membrane surfaces regulate assembly of ribonucleoprotein condensates.膜表面调节核糖核蛋白凝聚体的组装。
Nat Cell Biol. 2022 Apr;24(4):461-470. doi: 10.1038/s41556-022-00882-3. Epub 2022 Apr 11.
7
Essence determines phenomenon: Assaying the material properties of biological condensates.本质决定现象:生物凝聚物的物质性质分析。
J Biol Chem. 2022 Apr;298(4):101782. doi: 10.1016/j.jbc.2022.101782. Epub 2022 Mar 2.
8
The C-Terminal Domains of the PB2 Subunit of the Influenza A Virus RNA Polymerase Directly Interact with Cellular GTPase Rab11a.甲型流感病毒 RNA 聚合酶 PB2 亚基的 C 末端结构域直接与细胞 GTPase Rab11a 相互作用。
J Virol. 2022 Mar 9;96(5):e0197921. doi: 10.1128/jvi.01979-21. Epub 2022 Jan 12.
9
Deconstructing virus condensation.解析病毒凝聚
PLoS Pathog. 2021 Oct 14;17(10):e1009926. doi: 10.1371/journal.ppat.1009926. eCollection 2021 Oct.
10
Nucleation landscape of biomolecular condensates.生物分子凝聚物的成核景观。
Nature. 2021 Nov;599(7885):503-506. doi: 10.1038/s41586-021-03905-5. Epub 2021 Sep 22.